Literature DB >> 19375631

Coccidioidomycosis: a review of recent advances.

Neil M Ampel1.   

Abstract

Coccidioidomycosis is one of three dimorphic endemic mycoses recognized in North America. Over the past decade, the disease has been resurgent, particularly in the southwest United States. With this increase in incidence have come new observations and insights and re-examination of past issues. This article explores some of these areas by focusing principally on recent publications that are of importance.

Entities:  

Mesh：

Year:  2009        PMID： 19375631     DOI： 10.1016/j.ccm.2009.02.004

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN： 0272-5231            Impact factor:   2.878


  10 in total

1.  Chronic coccidioidomycosis endophthalmitis without concomitant systemic involvement: a clinicopathological case report.

Authors:  Daniel V Vasconcelos-Santos; Jennifer I Lim; Narsing A Rao
Journal:  Ophthalmology       Date:  2010-05-14       Impact factor: 12.079

2.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

Review 3.  Histopathologic diagnosis of fungal infections in the 21st century.

Authors:  Jeannette Guarner; Mary E Brandt
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

4.  Coccidioidomycosis with diffuse miliary pneumonia.

Authors:  David Sotello; Marcella Rivas; Audra Fuller; Tashfeen Mahmood; Menfil Orellana-Barrios; Kenneth Nugent
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-01

5.  Two cases illustrating successful adjunctive interferon-γ immunotherapy in refractory disseminated coccidioidomycosis.

Authors:  Christopher A Duplessis; Drake Tilley; Mary Bavaro; Braden Hale; Steven M Holland
Journal:  J Infect       Date:  2011-07-20       Impact factor: 6.072

6.  Construction and evaluation of a novel recombinant T cell epitope-based vaccine against Coccidioidomycosis.

Authors:  Brady J Hurtgen; Chiung-Yu Hung; Gary R Ostroff; Stuart M Levitz; Garry T Cole
Journal:  Infect Immun       Date:  2012-09-04       Impact factor: 3.441

Review 7.  A paradigm for the evaluation and management of spinal coccidioidomycosis.

Authors:  Nikolay L Martirosyan; Jesse M Skoch; Orel Zaninovich; Carmine Zoccali; John N Galgiani; Ali A Baaj
Journal:  Surg Neurol Int       Date:  2015-06-17

8.  Risk Factors and Epidemiology of Coccidioidomycosis Demonstrated by a Case of Spontaneous Pulmonary Rupture of Cavitary Coccidioidomycosis.

Authors:  Amy A Yau
Journal:  Case Rep Infect Dis       Date:  2016-01-24

9.  Infections of the nervous system.

Authors:  Vevek Parikh; Veronica Tucci; Sagar Galwankar
Journal:  Int J Crit Illn Inj Sci       Date:  2012-05

Review 10.  Coccidioidomycosis and the skin: a comprehensive review.

Authors:  Sandra Cecilia Garcia Garcia; Julio Cesar Salas Alanis; Minerva Gomez Flores; Sergio Eduardo Gonzalez Gonzalez; Lucio Vera Cabrera; Jorge Ocampo Candiani
Journal:  An Bras Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.896
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.